ConductScience.org, home

Paper41150737

In Silico Multitarget Profiling of Non-Selective Beta-Blockers Highlights Their Potential as Key Agents in Breast Cancer Adjuvant Therapy via ADRB2, ERBB2, and NPYR Receptors.

Muñoz-González F and 3 others. Curr Issues Mol Biol, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. In Silico Multitarget Profiling of Non-Selective Beta-Blockers Highlights Their Potential as Key Agents in Breast Cancer Adjuvant Therapy via ADRB2, ERBB2, and NPYR Receptors. Papers, record 41150737. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41150737

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In Silico Multitarget Profiling of Non-Selective Beta-Blockers Highlights Their Potential as Key Agents in Breast Cancer Adjuvant Therapy via ADRB2, ERBB2, and NPYR Receptors.
PubMed
Journal
Curr Issues Mol Biol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2025-10-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Muñoz-González FFelipehttps://orcid.org/0000-0002-4221-9479
2Correa-Basurto JJosé
3Ignacio-Mejia IIvánhttps://orcid.org/0000-0003-3792-4613
4Bandala CCindyhttps://orcid.org/0000-0002-7414-2621

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137193722Potential effect of chloroquine and propranolol combination to treat colorectal and triple-negative breast cancers.Sci Rep2023https://conductscience.org/library/papers/37193722PubMed
238126031Trial watch: beta-blockers in cancer therapy.Oncoimmunology2023https://conductscience.org/library/papers/38126031PubMed
332436935β-Blocker use is not associated with improved clinical outcomes in women with breast cancer: a meta-analysis.Biosci Rep2020https://conductscience.org/library/papers/32436935PubMed
426874901Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.Lancet Oncol2016https://conductscience.org/library/papers/26874901PubMed
529936294Serotonin and human cancer: A critical view.Biochimie2019https://conductscience.org/library/papers/29936294PubMed
635243626Contribution of adrenergic mechanisms for the stress-induced breast cancer carcinogenesis.J Cell Physiol2022https://conductscience.org/library/papers/35243626PubMed
735300360Drug-like Properties and Fraction Lipophilicity Index as a combined metric.ADMET DMPK2021https://conductscience.org/library/papers/35300360PubMed
830174436The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients.Onco Targets Ther2018https://conductscience.org/library/papers/30174436PubMed
929935594Effect of beta-blockers on cancer recurrence and survival: a meta-analysis of epidemiological and perioperative studies.Br J Anaesth2018https://conductscience.org/library/papers/29935594PubMed
1020332211Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line.Mol Cancer Res2010https://conductscience.org/library/papers/20332211PubMed
1126768715Alternative Viewpoint Against Breast Cancer Based on Selective Serotonin Receptors 5HTR3A and 5HTR2A Antagonists that can Mediate Apoptosis in MCF-7 Cell Line.Curr Drug Discov Technol2015https://conductscience.org/library/papers/26768715PubMed
122168286Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.Cancer Res1990https://conductscience.org/library/papers/2168286PubMed
1330542705β‑blockers inhibit the viability of breast cancer cells by regulating the ERK/COX‑2 signaling pathway and the drug response is affected by ADRB2 single‑nucleotide polymorphisms.Oncol Rep2019https://conductscience.org/library/papers/30542705PubMed
1427049669Small-Molecule Target Engagement in Cells.Cell Chem Biol2016https://conductscience.org/library/papers/27049669PubMed
1523912488The role of adrenergic signaling in breast cancer biology.Cancer Biomark2013https://conductscience.org/library/papers/23912488PubMed
1637264315Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling.BMC Cancer2023https://conductscience.org/library/papers/37264315PubMed
1735626710Interleukin-1 and Nuclear Factor Kappa B Signaling Promote Breast Cancer Progression and Treatment Resistance.Cells2022https://conductscience.org/library/papers/35626710PubMed
1836300620KEGG for taxonomy-based analysis of pathways and genomes.Nucleic Acids Res2023https://conductscience.org/library/papers/36300620PubMed
1921632503Beta blockers and breast cancer mortality: a population- based study.J Clin Oncol2011https://conductscience.org/library/papers/21632503PubMed
2031178382Beta-blockers: Historical Perspective and Mechanisms of Action.Rev Esp Cardiol (Engl Ed)2019https://conductscience.org/library/papers/31178382PubMed

See all 55 referencesDownload CSV of references

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADRB2154PubTator's text mininghttps://conductscience.org/library/genes/154NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
NPY1R4886PubTator's text mininghttps://conductscience.org/library/genes/4886NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41150737

GET https://conductscience.org/api/papers/v1/41150737/references?page=2